In connection with the ongoing rationalization and restructuring of its business operations, ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) is announcing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE